Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 220 participants.
Also called NCT07240467
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 220 participants
- Sponsor
- Registry
-
NCT07240467
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07240467. Randomized; quadruple masking; primary purpose treatment. Start 2025-12-15 (anticipated); primary completion 2028-12-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness
- Acronym
- ASCENT-BC
- Condition
- Acute Ischemic Stroke AIS
- Condition
- Impaired Consciousness
- Intervention (Drug)
- Bovis Calculus Stativus (BCS)
- Intervention (Drug)
- Placebo
- Lead sponsor
- Xiang Luo
- Collaborator
- The Fifth Hospital of Wuhan
- Collaborator
- Jingzhou Hospital of Traditional Chinese Medicine
- Collaborator
- Xiangyang Hospital of Traditional Chinese Medicine
- Collaborator
- Wuhan Hospital of Traditional Chinese Medicine
- Collaborator
- Hubei Hospital of Traditional Chinese Medicine
- Collaborator
- Wuhan No.1 Hospital
- Collaborator
- Wuhan Central Hospital
- Collaborator
- Xiangyang No.1 People's Hospital
- Collaborator
- Taihe Hospital affiliated to Hubei University of Medicine
- Collaborator
- Yichang Hospital of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct07240467- Content hash
d4fcf56568c47cb8b29cb268251977205bab5d920c55e584b219ecbf55afcaa2